Cordarone Injection 150mg

About Cordarone Injection 150mg

Cordarone Injection 150mg Uses

• Treats life-threatening ventricular fibrillation and pulseless ventricular tachycardia during cardiac arrest
• Controls acute, hemodynamically unstable ventricular arrhythmias in emergency and intensive care settings
• Used for rapid rhythm control in critically ill patients with atrial fibrillation
• Manages arrhythmias linked to Wolff-Parkinson-White syndrome in urgent situations

Cordarone Injection 150mg Benefits

• Provides fast onset of action for emergency rhythm control when oral therapy is not possible
• Included in advanced cardiac life support protocols for shock refractory cardiac arrest
• Effective in critically ill and hemodynamically unstable patients under close monitoring
• Allows precise, controlled intravenous dosing in a hospital setting

What Experts Say

Emergency physicians and cardiologists reach for intravenous amiodarone during cardiac arrest because it can restore a stable rhythm when defibrillation and epinephrine alone have failed. Its multi channel blocking action addresses several arrhythmia mechanisms at once.

Unlike the tablet form, IV amiodarone acts within minutes, which is why it sits at the center of advanced cardiac life support protocols for shock refractory ventricular fibrillation and pulseless ventricular tachycardia. Dosing follows a bolus then infusion pattern under continuous ECG and blood pressure monitoring.

Because rapid IV administration can cause hypotension and infusion site reactions, physicians dilute the drug carefully and infuse it through a central line whenever prolonged therapy is expected. Given Pakistan's rising burden of ischemic heart disease and cardiac arrest cases, reliable hospital access to this injectable formulation remains clinically important.

Drug Class

• Antiarrhythmic Agent (Class III)

Cordarone Injection 150mg formula

• Amiodarone Hydrochloride

Available forms

• Injection

How to use Cordarone Injection 150mg?

• Administered only by a doctor or trained healthcare professional in a hospital or emergency care setting
• Given as an intravenous injection or infusion, never self-administered at home
• Dosing follows an initial bolus dose followed by a continuous infusion, adjusted to response
• Requires continuous ECG and blood pressure monitoring throughout administration
• Given through a central line when infusion is prolonged, to reduce vein irritation

Drug Interactions

• Warfarin: Increases bleeding risk by raising warfarin blood levels, requiring closer INR monitoring
• Digoxin: Raises digoxin blood levels and increases the risk of toxicity, dose reduction is usually needed
• QT-Prolonging Drugs: Combining with certain antibiotics, antipsychotics, or antiarrhythmics raises the risk of dangerous rhythm changes
• Beta-Blockers And Calcium Channel Blockers: Combined IV use can cause severe bradycardia, low blood pressure, or heart block
• Statins: Increases the risk of muscle toxicity, especially with simvastatin
• Other Antiarrhythmic Drugs: Concurrent use raises the risk of additive proarrhythmic effects and needs close supervision

Risks and warnings

• Hypotension: Rapid IV administration commonly causes a sudden drop in blood pressure, requiring slow, monitored infusion
• Pulmonary Toxicity: Can cause serious, sometimes irreversible lung injury, especially with prolonged or repeated use
• Thyroid Dysfunction: High iodine content can trigger an underactive or overactive thyroid, monitored with periodic thyroid tests
• Liver Toxicity: May cause acute liver injury, particularly with rapid infusion, liver enzymes should be checked regularly
• Proarrhythmic Effect: Can worsen existing arrhythmias or cause new rhythm disturbances, continuous cardiac monitoring is essential
• Injection Site Reactions: May cause pain, redness, or thrombophlebitis at the infusion site, especially with peripheral lines
• Corneal Deposits And Photosensitivity: Can develop with repeated or prolonged use, similar to the oral form

Cordarone Injection 150mg Side Effects

• Low blood pressure during or after infusion
• Slow heart rate
• Pain, redness, or swelling at the injection site
• Nausea or vomiting
• Flushing
• Elevated liver enzymes
• Cough or shortness of breath suggesting lung involvement
• Thyroid function changes with repeated use
• Dizziness or lightheadedness

Storage Conditions

• Store below 25°C, away from direct light, and do not freeze
• Keep ampoules in their original carton until ready for use
• Dilute only with the recommended IV fluid immediately before administration
• Discard any unused, diluted solution right after use, do not store for later
• Keep out of reach of children and unauthorized personnel